To systematically study the effect of disulfiram on MLL1 in pediatric low- and high-grade glioma, we conducted a dose-response experiment on five well-characterized pediatric glioma cell lines of different grades (Supplementary Fig. 1a) [14]. The gene discussed is KMT2A; the disease is glioma.